Regulatory T-cell therapy (Sonoma Biotherapeutics)

N/A

Report date: 2024/04/07 14:02:33

Base Information

Drug NameRegulatory T-cell therapy (Sonoma Biotherapeutics)

Drug Alias NameTreg cell therapy (Sonoma Biotherapeutics)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionT lymphocyte replacements

TargetsUpdating

Therapy Area/IndicationsNeuritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSonoma Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesSonoma Biotherapeutics Inc

Inactive CompaniesN/A

Active IndicationsNeuritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A